Page 20 - 86_02
P. 20

16. Shinde RN, Sobhia ME. Binding and discerning interactions of PTP1B                                                               ANALES
   allosteric inhibitors: Novel insights from molecular dynamics simulations.                                                            RANF
   Journal of Molecular Graphics and Modelling. 2013;45:98-110
                                                                                                                                                     www.analesranf.com
17. Cui W, Cheng Y-H, Geng L-L, Liang D-S, Hou T-J, Ji M-J. Unraveling the
   Allosteric Inhibition Mechanism of PTP1B by Free Energy Calculation Based     30. Rodriguez R, Chinea G, Lopez N, Pons T, Vriend G. Homology modeling,
   on Umbrella Sampling. Journal of Chemical Information and Modeling.              model and software evaluation: three related resources. Bioinformatics.
   2013;53(5):1157-67.                                                              1998;14(6):523-8.

18. Zhang S, Chen L, Luo Y, Gunawan A, Lawrence DS, Zhang Z-Y. Acquisition       31. Case DA, Cheatham TE, 3rd, Darden T, Gohlke H, Luo R, Merz KM, Jr.,
   of a Potent and Selective TC-PTP Inhibitor via a Stepwise Fluorophore-           et al. The Amber biomolecular simulation programs. Journal of com-
   Tagged Combinatorial Synthesis and Screening Strategy. Journal of the            putational chemistry. 2005;26(16):1668-88.
   American Chemical Society. 2009;131(36):13072-9.
                                                                                 32. Ryckaert J-P, Ciccotti G, Berendsen HJC. Numerical integration of the
19. Li X, Wang L, Shi D. The design strategy of selective PTP1B inhibitors over     cartesian equations of motion of a system with constraints: molecular
   TCPTP. Bioorganic & Medicinal Chemistry. 2016;24(16):3343-52.                    dynamics of n-alkanes. Journal of Computational Physics.
                                                                                    1977;23(3):327-41.
20. Wade RC, Salo-Ahen OMH. Molecular Modeling in Drug Design. Molecules
   (Basel, Switzerland). 2019;24(2):321.                                         33. Woods CJ, Malaisree M, Hannongbua S, Mulholland AJ. A water-swap
                                                                                    reaction coordinate for the calculation of absolute protein–ligand bin-
21. Mendoza F, Gómez H, Lluch JM, Masgrau L. a1,4-N-Acetylhexosaminyl-              ding free energies. The Journal of Chemical Physics.
   transferase EXTL2: The Missing Link for Understanding Glycosidic Bond            2011;134(5):054114.
   Biosynthesis with Retention of Configuration. ACS Catalysis.
   2016;6(4):2577-89.                                                            34. Cui DS, Lipchock JM, Brookner D, Loria JP. Uncovering the Molecular
                                                                                    Interactions in the Catalytic Loop That Modulate the Conformational
22. Woods CJ, Malaisree M, Long B, McIntosh-Smith S, Mulholland AJ. Com-            Dynamics in Protein Tyrosine Phosphatase 1B. Journal of the American
   putational Assay of H7N9 Influenza Neuraminidase Reveals R292K Mu-               Chemical Society. 2019;141(32):12634-47.
   tation Reduces Drug Binding Affinity. Scientific Reports. 2013;3:3561.
                                                                                 35. Lamoree B, Hubbard RE. Current perspectives in fragment-based lead
23. Callegari D, Ranaghan KE, Woods CJ, Minari R, Tiseo M, Mor M, et al.            discovery (FBLD). Essays Biochem. 2017;61(5):453-64.
   L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-re-
   active conformation of the lung cancer drug osimertinib. Chemical Science.    8. MATERIAL COMPLEMENTARIO
   2018;9(10):2740-9.
                                                                                          Alineamiento de las secuencias generado con el programa
24. Liu X, Shi D, Zhou S, Liu H, Liu H, Yao X. Molecular dynamics simulations    modeller durante el proceso de modelado por homología.
   and novel drug discovery. Expert Opinion on Drug Discovery.
   2018;13(1):23-37.

25. Rudling A, Gustafsson R, Almlöf I, Homan E, Scobie M, Warpman Berglund
   U, et al. Fragment-Based Discovery and Optimization of Enzyme Inhibitors
   by Docking of Commercial Chemical Space. Journal of Medicinal Chemistry.
   2017;60(19):8160-9.

26. Wang T, Wu Z, Sun L, Li W, Liu G, Tang Y. A Computational Systems Phar-
   macology Approach to Investigate Molecular Mechanisms of Herbal For-
   mula Tian-Ma-Gou-Teng-Yin for Treatment of Alzheimer’s Disease.
   Frontiers in Pharmacology. 2018;9(668).

27. Shinde RN, Kumar GS, Eqbal S, Sobhia ME. Screening and identification
   of potential PTP1B allosteric inhibitors using in silico and in vitro appro-
   aches. PLOS ONE. 2018;13(6):e0199020

28. Šali A, Blundell TL. Comparative Protein Modelling by Satisfaction of Spa-
   tial Restraints. Journal of Molecular Biology. 1993;234(3):779-815.

29. Anandakrishnan R, Aguilar B, Onufriev AV. H++ 3.0: automating pK
   prediction and the preparation of biomolecular structures for atomistic
   molecular modeling and simulations. Nucleic Acids Research.
   2012;40(W1):W537-W41.

110  Proposal of a computational model for the study of the se-
     lectivity of allosteric inhibitors of PTP1B
     Javier García Marín
     An Real Acad Farm Vol. 86. Nº 2 (2020) · pp. 99 -112
   15   16   17   18   19   20   21   22   23   24   25